Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab in locoregionally-advanced nasopharyngeal carcinoma
NCT03700476Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Dec 2018
- Primary completion
- Feb 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of sintilimab in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
sintilimab
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT03700476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03700476.